Skip to main content

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

 


Market Overview:

During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry.

Competitive Landscape:

Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH).

Key Market Drivers:

Increasing developments by key players in the global pressure bandages market are expected to augment the growth of the market. For instance, in June 2019, Milliken & Company acquired Andover Healthcare, Inc. in order to provide comprehensive and innovative patient care solutions. In order to use a pressure bandage, the wound should be covered with an absorbent pad. This should be at least two inches thick. This allows the bandage to be properly secured and to distribute pressure evenly. The pad may be rolled cotton or sheet cotton. These types of bandages should be wrapped securely with adhesive tape to secure them to the wound. Moreover, the high incidence of surgical processes in the world is estimated to enhance the growth of the global pressure bandages market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, the global pressure bandages market witnessed several restraints. The sudden burden on the healthcare sector affected the end-use sectors. Moreover, lockdown measures and transport restrictions also impacted the market.

Key Takeaways:

·         North America is expected to dominate the growth of the global pressure bandages market, owing to the high developments by key players in the region. For instance, in May 2019, 3M acquired Acelity Inc. along with its KCI subsidiaries in order to expand the company's portfolio related to the wound care and pressure bandages market.

·         The Asia Pacific is estimated to witness high growth in the global pressure bandages market, owing to the increasing rate of surgeries in the region. For instance, according to Business Standard, around 20 million surgeries take place in India annually.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...
Post a Comment
Read more